Evidence map›Paper›PMID 42549902›Full record

ArticlemBio2026

SpxA1 and SpxA2 function as a stoichiometry-dependent regulatory rheostat governing virulence gene expression in group A

Gretchen A Morrison, Luis Alberto Vega, Misú Sanson Iglesias, Khufu Holly, W Hayes McDonald, Nicola Horstmann, Samuel A Shelburne, Jennifer A Gaddy, Anthony R Flores

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Gretchen A MorrisonDivision of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luis Alberto VegaDepartment of Microbiology and Molecular Genetics, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA.
Misú Sanson IglesiasDivision of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Khufu HollyDivision of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
W Hayes McDonaldMass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Nicola HorstmannDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Samuel A ShelburneDepartment of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0001-9721-263X
Jennifer A GaddyDivision of Infectious Disease, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-2192-4224
Anthony R FloresDivision of Pediatric Infectious Diseases, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-6402-4269

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Modular Automated -80C Sample Storage SystemS10OD025092 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 2019 to 2019
$2.0M
Contribution of LiaFSR to pathogenesis and carriage of group A StreptococcusR01AI125216 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FLORES, ANTHONY RICHARD · 2017 to 2021
$1.9M
Delineation of mechanisms underlying response regulator activation in group A StreptococcusR21AI177931 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SHELBURNE, SAMUEL A · 2024 to 2025
$439k
National Institute of Allergy and Infectious Diseases R01AI125216National Institute of Allergy and Infectious Diseases R21AI177931NCI NIH HHS P30 CA068485NCRR NIH HHS G20 RR030956NEI NIH HHS P30 EY008126NIAID NIH HHS R01 AI125216NIAID NIH HHS R21 AI177931NIH HHS S10 OD025092
6 · The paper itself

Abstract

Group A IMPORTANCE: Group A

Indexed as

Bacterial ProteinsGene Expression Regulation, BacterialStreptococcus pyogenesTranscription FactorsVirulence FactorsGene Expression ProfilingHumansOxidative StressProteomicsRegulonVirulenceBacterial ProteinsTranscription FactorsVirulence Factorscell envelope stress responseChIP-exoCovRS two-component systemgroup A StreptococcusSpx transcriptional regulator

Identifiers

PMID42549902
PMCPMC13556197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.